142 related articles for article (PubMed ID: 30688737)
21. 18F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine-Rituximab.
Lamonica D; Graf DA; Munteanu MC; Czuczman MS
J Nucl Med; 2017 Jan; 58(1):62-68. PubMed ID: 27469362
[TBL] [Abstract][Full Text] [Related]
22. In-111 ibritumomab scintigraphy (planar and SPECT) and FDG PET/CT before Y-90 ibritumomab treatment in a patient with mantle cell lymphoma.
Jiménez-Bonilla JF; Quirce R; Banzo I; Martínez-Rodríguez I; Sainz-Esteban A; Barragán JE; López-Cordovilla JJ; Carril JM
Clin Nucl Med; 2007 Dec; 32(12):952-3. PubMed ID: 18030051
[TBL] [Abstract][Full Text] [Related]
23. Diffuse skeletal muscle F-18 fluorodeoxyglucose uptake in advanced primary muscle non-Hodgkin's lymphoma.
Broski SM; Bou-Assaly W; Gross MD; Fig LM
Clin Nucl Med; 2009 Apr; 34(4):251-3. PubMed ID: 19300063
[TBL] [Abstract][Full Text] [Related]
24. Oropharyngeal Squamous Cell Carcinoma Metastasis to Distal Skeletal Muscle on FDG PET/CT.
Drew ZJ
Clin Nucl Med; 2018 Nov; 43(11):e402-e403. PubMed ID: 30179912
[TBL] [Abstract][Full Text] [Related]
25. Spontaneous regression of mantle cell lymphoma: a report of four cases.
Ye H; Desai A; Gong T; Zeng D; Nomie K; Chen W; Wang W; Romaguera J; Wang ML
Cancer Commun (Lond); 2018 May; 38(1):30. PubMed ID: 29843782
[TBL] [Abstract][Full Text] [Related]
26. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
[TBL] [Abstract][Full Text] [Related]
27. Perirenal Involvement of Mantle Cell Lymphoma: Imaging Features.
Ufuk F; Karaman E; Karabulut N
Urology; 2016 Nov; 97():e1-e3. PubMed ID: 27233934
[TBL] [Abstract][Full Text] [Related]
28. Multiple and solitary skeletal muscle metastases on 18F-FDG PET/CT imaging.
Nocuń A; Chrapko B
Nucl Med Commun; 2015 Nov; 36(11):1091-9. PubMed ID: 26275016
[TBL] [Abstract][Full Text] [Related]
29. Primary skeletal muscle lymphoma with unusual soft tissue metastases in the stomach and pancreas detected by 18F-FDG PET/CT.
Farahmandfar F; Shakeri S; Moradian S; Shahlaei S; Sadeghi R
Nucl Med Rev Cent East Eur; 2020; 23(2):108-109. PubMed ID: 33007100
[TBL] [Abstract][Full Text] [Related]
30. A pilot study to evaluate 3'-deoxy-3'-18F-fluorothymidine pet for initial and early response imaging in mantle cell lymphoma.
Herrmann K; Buck AK; Schuster T; Rudelius M; Wester HJ; Graf N; Scheuerer C; Peschel C; Schwaiger M; Dechow T; Keller U
J Nucl Med; 2011 Dec; 52(12):1898-902. PubMed ID: 22065875
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of [18F]-FDG-Based Hybrid Imaging Combinations for Assessment of Bone Marrow Involvement in Lymphoma at Initial Staging.
Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Staudenherz A; Senn D; Raderer M; Weber M; Simonitsch-Klupp I; Mayerhoefer ME
PLoS One; 2016; 11(10):e0164118. PubMed ID: 27723817
[TBL] [Abstract][Full Text] [Related]
32. Lymphoma Recurrence Along the Lymphatic Tract on 18F-FDG PET/CT Presenting as Lower Limb Swelling.
Sabiq S; Tham WY; Sinha AK; Loi HY
Clin Nucl Med; 2020 Feb; 45(2):139-140. PubMed ID: 31876814
[TBL] [Abstract][Full Text] [Related]
33. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F
Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT in primary brain lymphoma.
Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
36. Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
Albano D; Bosio G; Orlando E; Bertagna F
Hematol Oncol; 2017 Dec; 35(4):884-889. PubMed ID: 28004400
[TBL] [Abstract][Full Text] [Related]
37. 18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology.
Kothekar E; Yellanki D; Borja AJ; Al-Zaghal A; Werner TJ; Revheim ME; Gerke O; Saboury B; Gholamrezanezad A; Høilund-Carlsen PF; Alavi A
Nucl Med Commun; 2020 Feb; 41(2):162-168. PubMed ID: 31860525
[TBL] [Abstract][Full Text] [Related]
38. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
39. What is the role of 18F-fluorodeoxyglucose positron emission tomography in mantle cell lymphoma?
Gill S; Hicks RJ; Seymour JF
Leuk Lymphoma; 2008 Sep; 49(9):1653-6. PubMed ID: 18798097
[No Abstract] [Full Text] [Related]
40. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
Shao D; Tian XW; Gao Q; Liang CH; Wang SX
Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
